Results 21 to 30 of about 4,036 (152)

Etiology of parkinsonism in a Brazilian movement disorders clinic [PDF]

open access: yesArquivos de Neuro-Psiquiatria, 1998
OBJECTIVE: The aim of the present study is to investigate whether there are geographic differences in the etiology of parkinsonism (PA). BACKGROUND: 72% of patients with PA evaluated at movement disorders clinics in the Northern Hemisphere are diagnosed ...
FRANCISCO CARDOSO   +2 more
doaj   +1 more source

The Efficacy of Venlafaxine, Flunarizine, and Valproic Acid in the Prophylaxis of Vestibular Migraine

open access: yesFrontiers in Neurology, 2017
BackgroundDifferent types of medications are currently used in vestibular migraine (VM) prophylaxis, although recommendations for use are generally based on expert opinion rather than on solid data from randomized trials.
Fenye Liu   +4 more
doaj   +1 more source

A link between agrin signalling and Cav3.2 at the neuromuscular junction in spinal muscular atrophy

open access: yesScientific Reports, 2022
SMN protein deficiency causes motoneuron disease spinal muscular atrophy (SMA). SMN-based therapies improve patient motor symptoms to variable degrees. An early hallmark of SMA is the perturbation of the neuromuscular junction (NMJ), a synapse between a ...
Perrine Delers   +5 more
doaj   +1 more source

Molecular and clinical characteristics of ATP1A3-related diseases

open access: yesFrontiers in Neurology, 2022
ObjectiveWith detailed studies of ATP1A3-related diseases, the phenotypic spectrum of ATP1A3 has greatly expanded. This study aimed to potentially identify the mechanisms by which ATP1A3 caused neurological dysfunction by analyzing the clinical features ...
Yinchao Li   +9 more
doaj   +1 more source

Synthesis of [18F]flunarizine [PDF]

open access: yes, 1991
Flunarizine, a calcium channel antagonist of the piperazine class, has been labeled with the positron-emitter 18F. 4-[18F]Fluoro-4'-fluorobenzhydryl chloride was prepared in three steps from no-carrier-added [18F]fluoride ion, and used in the alkylation ...
Kilbourn, Michael R.
core   +1 more source

Flunarizine-loaded microparticles for the prophylaxis of migraine

open access: yes, 2020
The World Health Organization has listed migraine as the sixth most disabling disorder globally and the most disabling of all neurological disorders. Flunarizine (FZ) is considered a first-line prophylactic treatment for migraine in several guidelines ...
Sandoval, Virginia   +3 more
core   +1 more source

Alternating Hemiplegia of Childhood: Genotype–Phenotype Correlations in a Cohort of 39 Italian Patients

open access: yesFrontiers in Neurology, 2021
Alternating hemiplegia of childhood is a rare neurological disease characterized by paroxysmal movement disorders and chronic neurological disturbances, with onset before 18 months of age. Mutations in the ATP1A3 gene have been identified in up to 80% of
Ramona Cordani   +10 more
doaj   +1 more source

Flunarizine-induced Depression: A Case Report with Review of Literature [PDF]

open access: yesIndian Journal of Private Psychiatry
Aim and background: Flunarizine, a cerebro-selective calcium channel blocker, prescribed worldwide for migraine prophylaxis, has demonstrated efficacy and safety in different migraine types and patient populations, comparable to other first-line ...
Gagandeep Ahuja   +2 more
doaj   +1 more source

A Comparative Analysis of Amytripiline, Flunnarazine and Topiramate in the treatment of Primary Headache

open access: yesNepal Journal of Neuroscience, 2021
Introduction Primary headache disorder, characterized by recurrent headache is the most prevalent disease leading to widespread ill health and impaired quality of life.
Babu Ram Pokharel   +5 more
doaj   +1 more source

Novel E815K knock-in mouse model of alternating hemiplegia of childhood

open access: yesNeurobiology of Disease, 2018
De novo mutations causing dysfunction of the ATP1A3 gene, which encodes the α3 subunit of Na+/K+-ATPase pump expressed in neurons, result in alternating hemiplegia of childhood (AHC).
Ashley R. Helseth   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy